Hematology TimesDrugs may be effective against hematologic, other cancersJanuary 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLCMLAggressive Lymphomas
Hematology TimesCompany withdraws MAA for biosimilar pegfilgrastimDecember 29, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology Times‘Unprecedented’ MRD negativity with daratumumab in MMDecember 14, 2016Multiple Myeloma
Hematology NewsAutologous stem cell transplantation beat bortezomib regimen in myelomaDecember 13, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsStudy reinforces lenalidomide maintenance in newly diagnosed multiple myelomaDecember 11, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesGroup estimates global cancer cases, deaths in 2015December 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLALLHodgkin Lymphoma
Hematology NewsSecond transplant, consolidation don’t add benefit in upfront multiple myeloma therapyDecember 6, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsVIDEO: Venetoclax shows early good results in multiple myelomaDecember 4, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesNCCN releases new guidelines for cancer patientsDecember 1, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesEC grants ixazomib conditional approval to treat MMNovember 29, 2016Multiple MyelomaPharmacy
